Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 547

1.

MicroRNAs as markers of progression in cervical cancer: a systematic review.

Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A.

BMC Cancer. 2018 Jun 27;18(1):696. doi: 10.1186/s12885-018-4590-4.

2.

TAM 2.0: tool for MicroRNA set analysis.

Li J, Han X, Wan Y, Zhang S, Zhao Y, Fan R, Cui Q, Zhou Y.

Nucleic Acids Res. 2018 Jul 2;46(W1):W180-W185. doi: 10.1093/nar/gky509.

3.

Differentially expressed miRNAs in premature infants with retinopathy-a bioinformatics analysis.

Yang Y, Pan JJ, Zhou XG, Zhou XY, Cheng R.

Int J Ophthalmol. 2018 May 18;11(5):773-779. doi: 10.18240/ijo.2018.05.09. eCollection 2018.

4.

miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways.

Zhang X, Ren D, Wu X, Lin X, Ye L, Lin C, Wu S, Zhu J, Peng X, Song L.

Mol Ther Nucleic Acids. 2018 Jun 1;11:142-158. doi: 10.1016/j.omtn.2018.01.004. Epub 2018 Jan 31.

5.

Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma.

Wang Z, Zhang Z, Zhang C, Xu Y.

Oncol Lett. 2018 Jun;15(6):8491-8499. doi: 10.3892/ol.2018.8398. Epub 2018 Mar 30.

6.

MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2.

Yang N, Wang L, Liu J, Liu L, Huang J, Chen X, Luo Z.

Oncol Lett. 2018 Jun;15(6):8295-8302. doi: 10.3892/ol.2018.8395. Epub 2018 Mar 30.

7.

microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.

Pardini B, Cordero F, Naccarati A, Viberti C, Birolo G, Oderda M, Di Gaetano C, Arigoni M, Martina F, Calogero RA, Sacerdote C, Gontero P, Vineis P, Matullo G.

Oncotarget. 2018 Apr 17;9(29):20658-20669. doi: 10.18632/oncotarget.25057. eCollection 2018 Apr 17.

8.

MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer.

Ma M, Zhao J, Wu Q, Xiao K, Li S, Zhu H, Liu C, Xie H, Zuo C.

Cancer Med. 2018 Jun;7(6):2452-2462. doi: 10.1002/cam4.1520. Epub 2018 May 7.

9.

MicroRNA hsa-let-7e-5p as a potential prognosis marker for rectal carcinoma with liver metastases.

Chen W, Lin G, Yao Y, Chen J, Shui H, Yang Q, Wang X, Weng X, Sun L, Chen F, Yang S, Yang Y, Zhou Y.

Oncol Lett. 2018 May;15(5):6913-6924. doi: 10.3892/ol.2018.8181. Epub 2018 Mar 6.

10.

Prognostic value of circulating microRNAs in upper tract urinary carcinoma.

Montalbo R, Izquierdo L, Ingelmo-Torres M, Lozano JJ, Capitán D, Alcaraz A, Mengual L.

Oncotarget. 2018 Mar 30;9(24):16691-16700. doi: 10.18632/oncotarget.24672. eCollection 2018 Mar 30.

11.

Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression.

Liu M, Chen Y, Huang B, Mao S, Cai K, Wang L, Yao X.

Int J Oncol. 2018 Jun;52(6):1923-1933. doi: 10.3892/ijo.2018.4342. Epub 2018 Mar 29.

12.

Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.

Buschmann D, González R, Kirchner B, Mazzone C, Pfaffl MW, Schelling G, Steinlein O, Reithmair M.

Int J Oncol. 2018 Jun;52(6):1765-1776. doi: 10.3892/ijo.2018.4336. Epub 2018 Mar 27.

13.

Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.

Shen H, Wang W, Ni B, Zou Q, Lu H, Wang Z.

Int J Mol Med. 2018 Jul;42(1):21-30. doi: 10.3892/ijmm.2018.3594. Epub 2018 Mar 27.

14.

Fishing Into the MicroRNA Transcriptome.

Herkenhoff ME, Oliveira AC, Nachtigall PG, Costa JM, Campos VF, Hilsdorf AWS, Pinhal D.

Front Genet. 2018 Mar 19;9:88. doi: 10.3389/fgene.2018.00088. eCollection 2018. Review.

15.

Functional miRNAs in breast cancer drug resistance.

Hu W, Tan C, He Y, Zhang G, Xu Y, Tang J.

Onco Targets Ther. 2018 Mar 19;11:1529-1541. doi: 10.2147/OTT.S152462. eCollection 2018. Review.

16.

In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer.

Cava C, Bertoli G, Colaprico A, Bontempi G, Mauri G, Castiglioni I.

Int J Mol Sci. 2018 Mar 19;19(3). pii: E910. doi: 10.3390/ijms19030910.

17.

Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.

Chen P, Zhao L, Pan X, Jin L, Lin C, Xu W, Xu J, Guan X, Wu X, Wang Y, Yang S, Wang T, Lai Y.

Oncol Lett. 2018 Apr;15(4):5995-6002. doi: 10.3892/ol.2018.8081. Epub 2018 Feb 16.

18.

Analysis of microRNA and Gene Expression Profiles in Alzheimer's Disease: A Meta-Analysis Approach.

Moradifard S, Hoseinbeyki M, Ganji SM, Minuchehr Z.

Sci Rep. 2018 Mar 19;8(1):4767. doi: 10.1038/s41598-018-20959-0.

19.

miR-381-3p knockdown improves intestinal epithelial proliferation and barrier function after intestinal ischemia/reperfusion injury by targeting nurr1.

Liu L, Yao J, Li Z, Zu G, Feng D, Li Y, Qasim W, Zhang S, Li T, Zeng H, Tian X.

Cell Death Dis. 2018 Mar 14;9(3):411. doi: 10.1038/s41419-018-0450-z.

20.

Identification of potential genes and miRNAs associated with sepsis based on microarray analysis.

Li Y, Zhang F, Cong Y, Zhao Y.

Mol Med Rep. 2018 May;17(5):6227-6234. doi: 10.3892/mmr.2018.8668. Epub 2018 Mar 1.

Supplemental Content

Support Center